SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-23-074370
Filing Date
2023-06-26
Accepted
2023-06-23 17:58:03
Documents
3
Period of Report
2023-06-23

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2319588d1_pre14a.htm PRE 14A 159742
2 GRAPHIC tm2319588-1_img1.jpg GRAPHIC 3464
3 GRAPHIC tm2319588-1_img2.jpg GRAPHIC 4049
  Complete submission text file 0001104659-23-074370.txt   171533
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-15070 | Film No.: 231038959
SIC: 2834 Pharmaceutical Preparations